Table 8.

Volasertib pediatric leukemia trials in http://www.clinicaltrials.gov

Number	Abbreviated title	NCT number	Age	Sponsor
1	Open-label dose-escalating trial to determine the MTD-advanced cancers for whom no therapy is known	01971476	2–17 years	Boehringer Ingelheim

Notes: The search terms “volasertib leukemia children” rendered two hits. However, study NCT01721876 is in patients ≥65 years only. This study was not included in this table.

Abbreviations: NCT, National Clinical Trial; MTD, maximum tolerated dose.